logo-loader
viewTHC Global Group Ltd

THC Global has full suite of cannabis licences to advance farm-to-pharma model

In addition to its core Australian medicinal cannabis assets, THC has a significant Canadian presence – both in cannabis and in hydroponics equipment.

Ken Charteris
Group CEO Ken Charteris at the company's cannabis cultivation site at Bundaberg, Queensland. Photo credit: ABC Wide Bay, Kallee Buchanan

THC Global Group Ltd (ASX:THC) operates under a farm-to-pharma pharmaceutical model, now holding all three key cannabis licences being a Cannabis Research Licence, a Medicinal Cannabis Licence (Cultivation), and a Manufacture Licence.

The company has secured a significant cannabis growing capacity over multiple cultivation projects and owns a pharmaceuticals bio-manufacturing facility with attached testing and product development laboratory.

Bundaberg cannabis cultivation site manager John Hall. Photo credit: ABC Wide Bay, Kallee Buchanan

THC is in a prime position to commence medicinal cannabis production to service both domestic patients and the global export market.

The company is active globally with operations in Australia, New Zealand, and Canada and partnerships across Europe, Asia, and the Middle East.

In addition to its core Australian medicinal cannabis assets, THC has a significant Canadian presence – both in cannabis and in hydroponics equipment.

 

THC’s Canadian cannabis operation, Vertical Canna, holds property in Nova Scotia, Canada being developed into a large-scale cannabis production site.

The company’s hydroponics equipment division, Crystal Mountain, is a revenue generating manufacturer, wholesaler, and retailer of hydroponics equipment and supplies.

Quick facts: THC Global Group Ltd

Price: 0.415 AUD

ASX:THC
Market: ASX
Market Cap: $56.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.   "It's a significnat milestone ... we now are a farm-to-pharma process which...

on 13/6/19

2 min read